Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs

The Journal of Clinical Investigation
S K MoestrupE I Christensen

Abstract

Glycoprotein 330 (gp330) is an endocytic receptor expressed in the renal proximal tubules and some other absorptive epithelia, e.g., in the inner ear. The present study shows that the antifibrinolytic polypeptide, aprotinin, and the nephro- and ototoxic antibiotics, aminoglycosides, and polymyxin B compete for binding of 125I-urokinase-plasminogen activator inhibitor type-1 complexes to purified rabbit gp330. Half maximal inhibition was measured at 4 microM for aprotinin, 50 microM for gentamicin, and 0.5 microM for polymyxin B. Drug binding to gp330 was validated by equilibrium dialysis of [3H] gentamicin-gp330 incubations and binding/uptake studies in rat proximal tubules and gp330-expressing L2 carcinoma cells. Analyses of mutant aprotinins expressed in Saccharomyces cerevisiae revealed that basic residues are essential for the binding to gp330 and renal uptake. The polybasic drugs also antagonized ligand binding to the human alpha 2-macroglobulin receptor. However, the rapid glomerular filtration of the drugs suggests kidney gp330 to be the quantitatively most important target. In conclusion, a novel role of gp330 as a drug receptor is demonstrated. The new insight into the mechanism of epithelial uptake of polybasic drugs ...Continue Reading

References

Apr 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·W Liao, C H Florén
Oct 1, 1992·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·E I ChristensenS K Moestrup
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·R A OrlandoM G Farquhar
Dec 1, 1990·Hearing Research·J C de GrootJ E Veldman
Oct 1, 1990·The Journal of Infectious Diseases·G K BysaniM E Costlow
Jan 23, 1986·Biochimica Et Biophysica Acta·J Gliemann, O Davidsen
Apr 1, 1988·Kidney International·H D Humes
Jan 1, 1985·Archives of Oto-rhino-laryngology·T HayashidaT Kurata
Nov 1, 1980·Kidney International·J P MorinJ P Fillastre
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·D Kerjaschki, M G Farquhar
Apr 1, 1994·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·G ZhengR T McCluskey
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·I WarshawskyA L Schwartz
Sep 10, 1994·Annals of the New York Academy of Sciences·S K MoestrupJ Gliemann
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·A SaitoM G Farquhar
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R A Orlando, M G Farquhar

❮ Previous
Next ❯

Citations

Jul 23, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Steven M RoweDavid M Bedwell
Jun 14, 2008·Pflügers Archiv : European journal of physiology·Erik I ChristensenAndré W Brändli
Nov 14, 2008·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Detlef BockenhauerRobert Kleta
Nov 8, 2003·Journal of the Association for Research in Otolaryngology : JARO·P S SteygerC F Dai
Oct 31, 2007·Apoptosis : an International Journal on Programmed Cell Death·H ServaisM-P Mingeot-Leclercq
Apr 28, 2004·Advanced Drug Delivery Reviews·Nancy S Chung, Kishor M Wasan
Mar 17, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ayahisa WatanabeMikihisa Takano
Sep 30, 1999·Life Sciences·G DecortiF B Klugmann
Aug 8, 2001·Advanced Drug Delivery Reviews·B K NordskogP Tso
Apr 13, 2002·Hearing Research·Dalian DingRichard J Salvi
Apr 6, 1999·Hearing Research·K MizutaT Hoshino
Nov 30, 2000·Anesthesiology Clinics of North America·M Hladunewich, M H Rosenthal
Aug 6, 1998·Insect Biochemistry and Molecular Biology·T W Sappington, A S Raikhel
Jul 30, 2011·Integrative Biology : Quantitative Biosciences From Nano to Macro·Takatoshi Karasawa, Peter S Steyger
Mar 7, 2001·Kidney International·V SorribasM Levi
Aug 8, 2002·Kidney International·Pierre J VerroustErik Ilsø Christensen
Oct 10, 2002·Kidney International·Mikihisa TakanoJunya Nagai
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·S K MoestrupE Nexø
Mar 1, 1997·Molecular Biology of the Cell·R P CzekayM G Farquhar
Jan 1, 2013·Journal of Pediatric Hematology/oncology·Worawut ChoeyprasertSuradej Hongeng
Jun 13, 2012·Antimicrobial Agents and Chemotherapy·Kamilia AbdelraoufVincent H Tam
Jul 2, 2008·Antimicrobial Agents and Chemotherapy·Martti VaaraTimo Vaara
May 19, 2000·Antimicrobial Agents and Chemotherapy·N IsoherranenS Soback
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Hélène ServaisMarie-Paule Mingeot-Leclercq
Aug 17, 1999·Annual Review of Nutrition·M M HussainA Bakillah
Nov 29, 2011·International Journal of Otolaryngology·M E HuthA G Cheng
Sep 1, 1995·The Journal of Clinical Investigation·M G Farquhar
Nov 16, 2011·BMC Complementary and Alternative Medicine·Muhammad R KhanAisha Siddiquah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

The Journal of Biological Chemistry
Christian SchmitzT E Willnow
Proceedings of the National Academy of Sciences of the United States of America
A SaitoM G Farquhar
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
E I ChristensenS K Moestrup
Proceedings of the National Academy of Sciences of the United States of America
S K MoestrupE Nexø
© 2021 Meta ULC. All rights reserved